Imricor Medical Systems, Inc.

A$1.28As of Sun 8 Nov 2026, 12:00 UTC
ASX:IMRHealthcare
Country Australia
PE (Fwd) •••
TSR 7Y CAGR (1.28%)
Div yield —
ROE (143.12%)
Medical Devices
Beta (5Y) 0.49
PE TTM —
TSR TTM (10.18%)
Mkt cap A$459.1M
ROIC (30.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.38
8.15%
42.87%
Hold 7|9|9|5|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
(0.89%)
(0.51%)
7.50%
11.86%
Revenue$M
40.98
41.83
41.59
40.62
14.91%
11.20%
4.46%
3.66%
Peers (US$315.3M)
Cap (US$)
PE
316.3M
—
321.2M
25.74x
Capital
TTM
5Y
10Y
Leveragex
1.316
(0.168)
(0.134)
EBIT/Intx
2.496
0.337
0.290
Own earn%
1.25
73.74
73.04
Sh yield%
46.85
29.81
28.31
Owners
Insiders/Inst%
3.84
70.33
Short interest%
1.99
SBC / revenue%
5.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
27–35
$1 testx
−0.2
Incr. ROIC%
16